Anne Halenius
Overview
Explore the profile of Anne Halenius including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
970
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerke C, Bauersfeld L, Schirmeister I, Mireisz C, Oberhardt V, Mery L, et al.
Elife
. 2024 Jun;
13.
PMID: 38900146
Human leucocyte antigen class I (HLA-I) molecules play a central role for both NK and T-cell responses that prevent serious human cytomegalovirus (HCMV) disease. To create opportunities for viral spread,...
2.
Zimmermann C, Watson G, Bauersfeld L, Berry R, Ciblis B, Lan H, et al.
Proc Natl Acad Sci U S A
. 2024 Feb;
121(9):e2315985121.
PMID: 38377192
Recurrent, ancient arms races between viruses and hosts have shaped both host immunological defense strategies as well as viral countermeasures. One such battle is waged by the glycoprotein US11 encoded...
3.
Rein A, Lauruschkat C, Muchsin I, Kochel C, Tischer-Zimmermann S, Bauersfeld L, et al.
Blood Adv
. 2023 Dec;
8(3):712-724.
PMID: 38127299
Human cytomegalovirus (HCMV) reactivation poses a substantial risk to patients receiving tranplants. Effective risk stratification and vaccine development is hampered by a lack of HCMV-derived immunogenic peptides in patients with...
4.
Vollmer-Raschdorf S, Rashidi-Alavijeh J, Voigt S, Hengel H, Borchardt B, Huzly D, et al.
BMJ Open
. 2023 Nov;
13(11):e074461.
PMID: 37918931
Introduction: Shingrix, an effective adjuvanted, recombinant herpes zoster vaccine (RZV), has been available since 2018. Immunocompromised patients are known to be predisposed to vaccine failure. In-vitro testing of immunological surrogates...
5.
Baasch S, Giansanti P, Kolter J, Riedl A, Forde A, Runge S, et al.
Cell
. 2021 Jun;
184(14):3774-3793.e25.
PMID: 34115982
Cytomegaloviruses (CMVs) have co-evolved with their mammalian hosts for millions of years, leading to remarkable host specificity and high infection prevalence. Macrophages, which already populate barrier tissues in the embryo,...
6.
Seidel E, Dassa L, Kahlon S, Tirosh B, Halenius A, Seidel Malkinson T, et al.
Nat Commun
. 2021 Apr;
12(1):2061.
PMID: 33824318
Stress can induce cell surface expression of MHC-like ligands, including MICA, that activate NK cells. Human cytomegalovirus (HCMV) glycoprotein US9 downregulates the activating immune ligand MICA*008 to avoid NK cell...
7.
Kolb P, Hoffmann K, Sievert A, Reinhard H, Merce-Maldonado E, Le-Trilling V, et al.
Elife
. 2021 Mar;
10.
PMID: 33724188
Human cytomegalovirus (HCMV) is endowed with multiple highly sophisticated immune evasion strategies. This includes the evasion from antibody mediated immune control by counteracting host Fc-gamma receptor (FcγR) mediated immune control...
8.
Jongsma M, de Waard A, Raaben M, Zhang T, Cabukusta B, Platzer R, et al.
Immunity
. 2021 Feb;
54(2):387.
PMID: 33567263
No abstract available.
9.
de Waard A, Verkerk T, Jongsma M, Hoefakker K, Sethumadhavan S, Gerke C, et al.
Eur J Immunol
. 2020 Dec;
51(3):734-737.
PMID: 33275281
A single model system for integrative studies on multiple facets of antigen presentation is lacking. PAKC is a novel panel of ten cell lines knocked out for individual components of...
10.
Jongsma M, de Waard A, Raaben M, Zhang T, Cabukusta B, Platzer R, et al.
Immunity
. 2020 Dec;
54(1):132-150.e9.
PMID: 33271119
HLA class I (HLA-I) glycoproteins drive immune responses by presenting antigens to cognate CD8 T cells. This process is often hijacked by tumors and pathogens for immune evasion. Because options...